Co-Authors
This is a "connection" page, showing publications co-authored by Erica Wood and Zoe McQuilten.
Connection Strength
3.330
-
How should we use convalescent plasma therapies for the management of COVID-19? Blood. 2021 03 25; 137(12):1573-1581.
Score: 0.936
-
Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review. Transfus Med Rev. 2018 01; 32(1):6-15.
Score: 0.724
-
Erratum to "Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk" (Transfusion Medicine Reviews 31/3 [2017] 154-164). Transfus Med Rev. 2018 01; 32(1):66-68.
Score: 0.182
-
Fibrinogen concentration and use of fibrinogen supplementation with cryoprecipitate in patients with critical bleeding receiving massive transfusion: a bi-national cohort study. Br J Haematol. 2017 10; 179(1):131-141.
Score: 0.181
-
Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk. Transfus Med Rev. 2017 07; 31(3):154-164.
Score: 0.179
-
Fibrinogen is an independent predictor of mortality in major trauma patients: A five-year statewide cohort study. Injury. 2017 May; 48(5):1074-1081.
Score: 0.173
-
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 09 02; 9:CD013825.
Score: 0.060
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 05 20; 5:CD013600.
Score: 0.059
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 10 12; 10:CD013600.
Score: 0.057
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
Score: 0.057
-
Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities. Vox Sang. 2021 Jan; 116(1):88-98.
Score: 0.056
-
Vox Sanguinis International Forum on Hospital Transfusion Services' Response to COVID-19: Responses. Vox Sang. 2020 08; 115(6):e1-e17.
Score: 0.056
-
Vox Sanguinis International Forum on transfusion services' response to COVID-19: Summary. Vox Sang. 2020 08; 115(6):536-542.
Score: 0.056
-
Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in Humans. ACS Sens. 2020 08 28; 5(8):2596-2603.
Score: 0.056
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 07 10; 7:CD013600.
Score: 0.056
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Cochrane Database Syst Rev. 2020 05 14; 5:CD013600.
Score: 0.055
-
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust. 2020 06; 212(10):481-489.
Score: 0.055
-
Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry. Clin Lymphoma Myeloma Leuk. 2019 08; 19(8):e415-e424.
Score: 0.051
-
Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey. Intern Med J. 2019 Mar; 49(3):358-363.
Score: 0.051
-
Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study. Semin Thromb Hemost. 2019 Mar; 45(2):187-195.
Score: 0.050
-
Major haemorrhage fatalities in the Australian national coronial database. Emerg Med Australas. 2018 06; 30(3):382-388.
Score: 0.047
-
Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus. Med J Aust. 2017 Jun 05; 206(10):455-460.
Score: 0.045
-
Red cell transfusion thresholds in myelodysplastic syndromes: a clinician survey to inform future clinical trials. Intern Med J. 2017 Jun; 47(6):695-698.
Score: 0.045
-
Myeloma in the Real World: What Is Really Happening? Clin Lymphoma Myeloma Leuk. 2017 03; 17(3):133-144.e1.
Score: 0.044